DXCM

DexCom, Inc.

79.93

USD

+1.31

+1.67%

Oct 29, 15:59 UTC -4

Closed

Pre-Market

82.78

+2.84

+3.56%

DexCom, Inc. (DXCM) Earnings

DXCM Earnings Reports

Positive Surprise Ratio

DXCM beat 33 of 43 last estimates.

77%

Next Report

Date of Next Report

Feb 10, 2027

Estimate for Q4 26 (Revenue/ EPS)

$1.43B

$0.74

Implied change from Q3 26 (Revenue/ EPS)

Implied change from Q4 25 (Revenue/ EPS)

+19.92%

+64.44%

DexCom, Inc. earnings per share and revenue

On Oct 22, 2026, DXCM reported earnings of -- USD per share (EPS) for Q3 26, -- the estimate of 0.68 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 1.35 billion, with a --% difference.

Looking ahead to Q4 26, -- analysts forecast an EPS of 0.74 USD, with revenue projected to reach 1.43 billion USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Intuitive Surgical Inc.

Report Date

Oct 20, 2026 For Q3 26

Estimate

$2.69

Actual

$3.00

Surprise

+11.29%

IQVIA Holdings Inc.

Report Date

Oct 27, 2026 For Q3 26

Estimate

$3.30

Actual

$3.34

Surprise

+0.97%

Glaukos Corporation

Report Date

Oct 28, 2026 For Q3 26

Estimate

-$0.09

Actual

$0.47

Surprise

+611.98%

Thermo Fisher Scientific, Inc.

Report Date

Oct 21, 2026 For Q3 26

Estimate

$6.46

Actual

$6.68

Surprise

+3.29%

Axogen, Inc. Common Stock

Report Date

Oct 28, 2026 For Q3 26

Estimate

$0.14

Actual

$0.21

Surprise

+47.06%

Alphatec Holdings, Inc.

Report Date

Oct 29, 2026 For Q3 26

Estimate

$0.09

Actual

$0.09

Surprise

-6.83%

Beta Bionics, Inc. Common Stock

Report Date

Oct 27, 2026 For Q3 26

Estimate

-$0.53

Actual

-$0.52

Surprise

+2.73%

Integra LifeSciences Holdings

Report Date

Oct 21, 2026 For Q3 26

Estimate

$0.57

Actual

$0.59

Surprise

+3.04%

OrthoPediatrics Corp. Common Stock

Report Date

Oct 27, 2026 For Q3 26

Estimate

-$0.21

Actual

-$0.23

Surprise

-4.88%

ClearPoint Neuro, Inc. Common Stock

Report Date

Oct 28, 2026 For Q3 26

Estimate

-$0.32

Actual

-$0.24

Surprise

+25.30%

FAQ

What were DexCom, Inc.'s earnings and revenue for the latest quarter Q3 2026?

For Q3 2026, DexCom, Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to DexCom, Inc.'s Q3 2026 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is DexCom, Inc. expected to report next?

The next earning report is scheduled for Feb 10, 2027.

What are the forecasts for DexCom, Inc.'s next earnings report?

Based on -- analysts, DexCom, Inc. is expected to report EPS of $0.74 and revenue of $1.43B for Q4 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.